نتائج البحث - Massimo Di Nicola

تنقيح النتائج
  1. 1
    Lymphoma Immunotherapy: Current Status

    Lymphoma Immunotherapy: Current Status حسب Roberta Zappasodi, Filippo de Braud, Massimo Di Nicola

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy

    Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy حسب Giovanni Fucá, Andrea Spagnoletti, Margherita Ambrosini, Filippo de Braud, Massimo Di Nicola

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer

    Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer حسب Marco Bregni, Michele Magni, Salvatore Siena, Massimo Di Nicola, Gianni Bonadonna, AM Gianni

    منشور في 1992
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

    Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli حسب Massimo Di Nicola, Carmelo Carlo‐Stella, Michele Magni, Marco Milanesi, Paolo Longoni, Paola Matteucci, Salvatore Grisanti, Alessandro M. Gianni

    منشور في 2002
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells

    The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor... حسب Roberta Zappasodi, Massimo Di Nicola, Carmelo Carlo‐Stella, Roberta Mortarini, Annie Molla, Claudia Vegetti, Salvatore Albani, Andrea Anichini, Alessandro M. Gianni

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    High-Dose Yttrium-90–Ibritumomab Tiuxetan With Tandem Stem-Cell Reinfusion: An Outpatient Preparative Regimen for Autologous Hematopoietic Cell Transplantation

    High-Dose Yttrium-90–Ibritumomab Tiuxetan With Tandem Stem-Cell Reinfusion: An Outpatient Preparative Regimen for Autologous Hematopoietic Cell Transplantation حسب Liliana Devizzi, Anna Guidetti, Corrado Tarella, Michele Magni, Paola Matteucci, Ettore Seregni, Carlo Chiesa, Emilio Bombardieri, Massimo Di Nicola, Carmelo Carlo‐Stella, Alessandro M. Gianni

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Specific Ctls but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions

    An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Spe... حسب Andrea Anichini, Alessandra Molla, Roberta Mortarini, Gabrina Tragni, Ilaria Bersani, Massimo Di Nicola, Alessandro M. Gianni, Silvana Pilotti, P. Rod Dunbar, Vincenzo Cerundolo, Giorgio Parmiani

    منشور في 1999
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

    High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma حسب Alessandro M. Gianni, Marco Bregni, Salvatore Siena, Cristina Brambilla, Massimo Di Nicola, Fabrizio Lombardi, Lorenza Gandola, Corrado Tarella, Alessandro Pileri, Fernando Ravagnani, Pinuccia Valagussa, Gianni Bonadonna

    منشور في 1997
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death

    Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death حسب Roberta Zappasodi, Serenella M. Pupa, Gaia C. Ghedini, Italia Bongarzone, Michele Magni, Antonello D. Cabras, Mario P. Colombo, Carmelo Carlo‐Stella, Alessandro M. Gianni, Massimo Di Nicola

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities

    SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities حسب Sabina Sangaletti, Giovanna Talarico, Claudia Chiodoni, Barbara Cappetti, Laura Botti, Paola Portararo, Alessandro Gulino, Francesca Maria Consonni, Antonio Sica, Giovanni Randon, Massimo Di Nicola, Claudio Tripodo, Mario P. Colombo

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study

    Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pil... حسب Massimo Di Nicola, Roberta Zappasodi, Carmelo Carlo‐Stella, Roberta Mortarini, Serenella M. Pupa, Michele Magni, Liliana Devizzi, Paola Matteucci, Paola Baldassari, Fernando Ravagnani, Antonello D. Cabras, Andrea Anichini, Alessandro M. Gianni

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma

    HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma حسب Roberta Zappasodi, Giusi Ruggiero, Carla Guarnotta, Monica Tortoreto, Cristina Tringali, Alessandra Cavanè, Antonello D. Cabras, Lorenzo Castagnoli, Bruno Venerando, Nadia Zaffaroni, Alessandro M. Gianni, Filippo de Braud, Claudio Tripodo, Serenella M. Pupa, Massimo Di Nicola

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer

    WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer حسب Lorenzo Castagnoli, Valeria Cancila, Sandra Romero‐Córdoba, Simona Faraci, Giovanna Talarico, Beatrice Belmonte, Marilena V. Iorio, Matteo Milani, Tatiana Volpari, Claudia Chiodoni, Alfredo Hidalgo‐Miranda, Elda Tagliabue, Claudio Tripodo, Sabina Sangaletti, Massimo Di Nicola, Serenella M. Pupa

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial

    Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial حسب Luis Paz‐Ares, Tae Min Kim, David Vicente, Enriqueta Felip, Dae Ho Lee, Ki Hyeong Lee, Chia‐Chi Lin, M.J. Flor, Massimo Di Nicola, Rosa Álvarez, Isabelle Dussault, Christoph Helwig, Laureen S. Ojalvo, James L. Gulley, Byoung Chul Cho

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus–associated lymphoid malignancies

    A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus–associated lymphoid malignancies حسب Susan P. Perrine, Olivier Hermine, Trudy N. Small, Felipe Suárez, Richard J. O’Reilly, Farid Boulad, Joyce D. Fingeroth, Melissa Askin, Arthur Levy, Steven J. Mentzer, Massimo Di Nicola, Alessandro M. Gianni, Christoph A. Klein, Steven M. Horwitz, Douglas V. Faller

    منشور في 2006
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients

    Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients حسب Lorena Passoni, Luca Longo, Paola Collini, Addolorata Maria Luce Coluccia, Fabio Bozzi, Marta Podda, Andrea Gregorio, Claudio Gambini, Alberto Garaventa, Vito Pistoia, Federica Grosso, Gian Paolo Tonini, Mangeng Cheng, Carlo Gambacorti‐Passerini, Andrea Anichini, Franca Fossati‐Bellani, Massimo Di Nicola, Roberto Luksch

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial

    High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary C... حسب Andrés J.M. Ferreri, Giovanni Donadoni, Maria Giuseppina Cabras, Caterina Patti, Michael Mian, Renato Zambello, Corrado Tarella, Massimo Di Nicola, Alfonso Maria D’Arco, Gianluca Doa, Marta Bruno‐Ventre, Andrea Assanelli, Marco Foppoli, Giovanni Citterio, Alessandro Fanni, Antonino Mulè, Federico Caligaris‐Cappio, Fabio Ciceri

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma

    Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients... حسب Corrado Tarella, Roberto Passera, Michele Magni, Fabio Benedetti, Andrea Rossi, Angela Gueli, Caterina Patti, Guido Parvis, Fabio Ciceri, Andrea Gallamini, Sergio Cortelazzo, Valerio Zoli, Paolo Corradini, Alessandra Carobbio, Antonino Mulè, Marco Bosa, Anna Maria Barbui, Massimo Di Nicola, Marco Sorio, Daniele Caracciolo, Alessandro M. Gianni, Alessandro Rambaldi

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

    A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previous... حسب Marek Trněný, Gregor Verhoef, Martin J.S. Dyer, Dina Ben Yehuda, Caterina Patti, Miguel Canales, Andrés López, Farrukh T. Awan, Paul G. Montgomery, Andrea Janíková, Anna Maria Barbui, K Sułek, María José Terol, John Radford, Anna Guidetti, Massimo Di Nicola, Laure Siraudin, Laurence Hatteville, Sandrine Schwab, Corina Oprea, Alessandro M. Gianni

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor–Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors

    Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor–Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Adva... حسب Kimberley M. Heinhuis, Matteo S. Carlino, Markus Joerger, Massimo Di Nicola, Tarek Meniawy, Sylvie Rottey, Víctor Moreno, Anas Gazzah, Jean‐Pierre Delord, Luis Paz‐Ares, Christian Britschgi, Russell J. Schilder, Kenneth J. O’Byrne, Giuseppe Curigliano, Emanuela Romano, Poliana Patah, Rui Wang, Yali Liu, Gaurav Bajaj, Lillian L. Siu

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: